Literature DB >> 122714

Effects of pyrithiamin and oxythiamin on acetylcholine levels and utilization in rat brain.

C V Vorhees1, D E Schmidt, R J Barrett.   

Abstract

Regional cerebral acetylcholine (ACh) levels and utilization rate were assessed in vivo in rats rendered thiamin deficient using the thiamin antagonists pyrithiamin or oxythiamin. ACh levels were significantly reduced in all brain regions of pyrithiamin treated rats and in the medulla-pons and striatum of oxythiamin treated rats compared to controls. ACh utilization was significantly reduced in the midbrain, striatum and hippocampus of pyrithiamin treated rats, but was reduced only in the striatum of oxythiamin treated rats compared to controls. Thus, there are some reductions in ACh levels and utilization that are unique to pyrithiamin induced deficiency and as such are distinct from oxythiamin/undernutrition related reductions. Since only pyrithiamin produces neurological symptoms, its unique ACh effects may be related to these symptoms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 122714     DOI: 10.1016/0361-9230(78)90078-3

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  9 in total

Review 1.  Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models.

Authors:  P J Langlais; S X Zhang; L M Savage
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

2.  Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.

Authors:  N Y Calingasan; S E Gandy; H Baker; K F Sheu; J D Smith; B T Lamb; J D Gearhart; J D Buxbaum; C Harper; D J Selkoe; D L Price; S S Sisodia; G E Gibson
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

3.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy: 1. The pyruvate dehydrogenase complex.

Authors:  R F Butterworth; J F Giguere; A M Besnard
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

4.  Experimentally-induced Wernicke's encephalopathy modifies crucial rat brain parameters: the importance of Na+, K+ -ATPase and a potentially neuroprotective role for antioxidant supplementation.

Authors:  Apostolos Zarros; Charis Liapi; Hussam Al-Humadi; Marianna Almpani; Vasileios Stolakis; Nikolina Skandali; Konstantinos Voumvourakis; Eleni Katsouni; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2013-03-12       Impact factor: 3.584

5.  Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal.

Authors:  G E Gibson; H Ksiezak-Reding; K F Sheu; V Mykytyn; J P Blass
Journal:  Neurochem Res       Date:  1984-06       Impact factor: 3.996

6.  GABA-transaminase and glutamic acid decarboxylase changes in the brain of rats treated with pyrithiamine.

Authors:  S G Thompson; E G McGeer
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

7.  Increasing hippocampal acetylcholine levels enhance behavioral performance in an animal model of diencephalic amnesia.

Authors:  Jessica J Roland; Katherine Mark; Ryan P Vetreno; Lisa M Savage
Journal:  Brain Res       Date:  2008-08-05       Impact factor: 3.252

8.  Activities of thiamine-dependent enzymes in two experimental models of thiamine deficiency encephalopathy: 3. Transketolase.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

9.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. alpha-Ketoglutarate dehydrogenase.

Authors:  R F Butterworth; J F Giguère; A M Besnard
Journal:  Neurochem Res       Date:  1986-04       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.